Morning Overview on MSN
A massive long-term review just tied GLP-1 weight-loss drugs to sharply lower rates of heart attacks, strokes, heart failure, and early death
When the results of the SELECT trial landed in the New England Journal of Medicine in November 2023, they confirmed what ...
Everyday Health on MSN
GLP-1 drugs for obesity: How to switch from the needle to a pill
Learn how to transition from injectable GLP-1s to oral options like Wegovy and Foundayo, with expert advice on dosing, side ...
Health Canada approved both Dr. Reddy's and Apotex's generic semaglutide — the active ingredient in brand-name Ozempic and ...
GLP-1 drugs tirzepatide and semaglutide may offer increased protection against heart attack, stroke and death from any cause, according to a November study published in Nature Medicine and presented ...
Tirzepatide and semaglutide are popular weight loss drugs. Learn how they differ in effectiveness, cost, and side effects.
In a phase III trial, orforglipron yielded better HbA1c reduction compared with oral semaglutide at 52 weeks. Gastrointestinal side effects were more common with orforglipron, leading to more ...
Scripps case series suggests some patients can maintain GLP-1 weight loss by spacing semaglutide or tirzepatide doses.
GIP infusion as add-on to placebo or semaglutide did not improve glycaemic control in individuals with type 2 diabetes at the prespecified target of 1·50 mmol/L. Due to dropouts, we cannot draw firm ...
When Terra Field started taking Wegovy for weight loss in 2022, she finally understood what satiety truly felt like. “It felt the way I thought my body should have been operating the entire time,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results